A phase II clinical study of iNKT cell therapy (AGENT 797)
Latest Information Update: 12 Feb 2021
At a glance
- Drugs AGENT-797 (Primary)
- Indications SARS-CoV-2 acute respiratory disease
- Focus Therapeutic Use
- 12 Feb 2021 New trial record
Latest Information Update: 12 Feb 2021